Results 11 to 20 of about 3,399,085 (314)
Seminars in Nuclear Medicine, 2012 This review addresses the specific contributions of nuclear medicine techniques, and especially positron emission tomography (PET), for diagnosis and management of brain tumors. (18)F-Fluorodeoxyglucose PET has particular strengths in predicting prognosis and differentiating cerebral lymphoma from nonmalignant lesions.
Herholz, Karl; id_orcid 0000-0002-8658-0151 +3 more
openaire +5 more sources
The Korean Society for Neuro-Oncology (KSNO) guideline for antiepileptic drug usage of brain tumor: Version 2021.1 [PDF]
, 2021 Background: To date, there has been no practical guidelines for the prescription of antiepileptic drugs (AEDs) in brain tumor patients in Korea. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, had begun preparing
김세훈, 윤홍인, 장종희
core +1 more source
Recent Update on Neurosurgical Management of Brain Metastasis [PDF]
, 2022 Brain metastasis (BM), classified as a secondary brain tumor, is the most common malignant central nervous system tumor whose median overall survival is approximately 6 months.
박현호 +3 more
core +1 more source
Dysembryoplastic Neuroepithelial Tumor: A Benign but Complex Tumor of the Cerebral Cortex [PDF]
, 2022 Dysembryoplastic neuroepithelial tumor (DNET) is a distinct type of low-grade glioneuronal tumor. Clinically, DNET is highly associated with intractable epilepsy in young children and adolescents.
김세훈
core +1 more source
CA: A Cancer Journal for Clinicians, 1993 At the same time that studies indicate an increase in the frequency of brain tumors, improvements in diagnosis and treatment have increased the clinician's ability to deal with these cancers. Dr. Posner, Chairman of the Department of Neurology at Memorial Sloan-Kettering Cancer Center in New York City, encourages physicians to be alert for symptoms of ...
E R, Laws, K, Thapar
openaire +4 more sources
Cell Death and Disease, 2022 Patients with glioblastoma (GBM) have poor prognosis and limited treatment options, largely due to therapy resistance upon the induction of apoptosis.
Xiaodong Su +6 more
doaj +1 more source
Intracranial Extraskeletal Myxoid Chondrosarcoma in Fourth Ventricle [PDF]
, 2021 We present an extremely rare case of intracranial extraskeletal myxoid chondrosarcoma. A 36-year-old male presented with dizziness persisting for 2 weeks. MRI of the patient showed well-enhanced mass of fourth ventricle.
김세훈, 장종희, 유지환
core +1 more source
A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma [PDF]
, 2020 Background: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted the nationwide questionnaire survey for diverse queries facing to treat patients with brain tumor.
김세훈, 윤홍인, 장종희
core +1 more source
A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid Usage [PDF]
, 2020 Background: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part I of the survey, the aim of this study is to evaluate
김세훈, 윤홍인, 장종희
core +1 more source
The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1 [PDF]
, 2021 Background: There have been no guidelines for the management of adult patients with diffuse midline glioma (DMG), H3K27M-mutant in Korea since the 2016 revised WHO classification newly defined this disease entity.
김세훈 +3 more
core +1 more source